June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Choroidal Structural Changes in Vogt-Koyanagi-Harada disease after treatment determined by Binarization of EDI-OCT images
Author Affiliations & Notes
  • Hiroki Kawano
    Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
  • Taiji Sakamoto
    Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
  • Shozo Sonoda
    Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
  • Ichiro Maruko
    Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan
  • Tomohiro Iida
    Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships Hiroki Kawano, None; Taiji Sakamoto, None; Shozo Sonoda, None; Ichiro Maruko, None; Tomohiro Iida, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 6170. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hiroki Kawano, Taiji Sakamoto, Shozo Sonoda, Ichiro Maruko, Tomohiro Iida; Choroidal Structural Changes in Vogt-Koyanagi-Harada disease after treatment determined by Binarization of EDI-OCT images. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):6170.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: It is well known that the choroidal thickness of Vogt-Koyanagi-Harada syndrome (VKH) in acute phase is thick and decreases quickly with corticosteroid treatment by using enhance depth imaging OCT (EDI-OCT) technique. The choroidal thickness would be certainly the important marker; however, it is not enough to represent every disease condition. Our purpose is to see the structural changes of choroid in the VKH by analyzing the OCT image using binarization technique.

Methods: This study included 32 eyes of 16 patients (2 men and 14 women) with VKH and a retrospective case-series. Choroidal images were recorded by EDI-OCT at baseline and 1 week and 1 month after the initiating steroid therapy. The EDI-OCT image was converted to binarization image by a modified Niblack method by ImageJ (version 1.47; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA; http://imagej.nih.gov/ij/). The luminal area and the stromal area were separately measured and analyzed.

Results: The choroidal area was 472 ± 63 × 104 µm2 (stromal area 188 ± 34 ×104 µm2 and luminal area 285 ± 32 ×104 µm2 ) at baseline, which significantly decreased after the treatment 243 ± 44 ×104 µm2 (stromal area 80 ± 13 × 104 µm2 and luminal area 163 ± 34 × 104 µm2 ) at 1 week (P < 0.01) and 217 ± 47 × 104 µm2 (stromal area 73 ± 14 × 104 µm2 and luminal area 143 ± 35 ×104 µm2 ) at 1 month (P < 0.01). Although both of stromal and luminal areas reduced its size, the reduction rate of stromal area (56.5 ± 7.2 %) was significantly greater than luminal area (42.5 ± 12.6 %) from baseline to 1 week (P < 0.01, Mann-Whitney U test). While, the reduction percentage of luminal area from baseline to 1 month was 48.9 ± 14.5 %, and that of stromal area was 59.7 ± 10.4 %, which was insignificant (P = 0.09).

Conclusions: In the choroid of VKH at very early phase of treatment, the stromal area decreased more than luminal area, subsequently both areas decreased similarly. They may reflect the initial disappearance of stromal edema or infiltrating cells, which was detected by the binarization technique.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×